Immediate Impact
32 standout
Citing Papers
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
2025 Standout
Revolutionizing prostate cancer therapy: Artificial intelligence – Based nanocarriers for precision diagnosis and treatment
2025 Standout
Works of Juening Kang being referenced
Abstract A043: Identifying tumor heterogeneity and drug sensitivity in primary prostate cancer towards personalized medicine
2023
Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF‐κB and NLRP3 inflammasome
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Juening Kang | 207 | 144 | 42 | 46 | 10 | 354 | |
| Yuji Higashibata | 139 | 121 | 48 | 48 | 9 | 319 | |
| Liron Berger | 74 | 170 | 99 | 87 | 10 | 374 | |
| Sean A. Hardy | 85 | 140 | 34 | 40 | 11 | 403 | |
| Caroline Coletti | 115 | 147 | 13 | 27 | 12 | 404 | |
| Patrick Crosswhite | 199 | 121 | 23 | 22 | 11 | 379 | |
| Jianliang Wu | 142 | 143 | 107 | 60 | 15 | 371 | |
| John F. Dimari | 80 | 134 | 156 | 69 | 8 | 404 | |
| Yonglun Kong | 72 | 143 | 63 | 37 | 16 | 305 | |
| Masayuki Usami | 76 | 141 | 14 | 38 | 18 | 355 | |
| Weixiang He | 98 | 179 | 12 | 27 | 20 | 336 |
All Works
Login with ORCID to disown or claim papers
Loading papers...